AMGEN, S.A secures contract for Various medicinal products Supply of the active ingredient called "BLINATUMOMAB 38.5 MCG VIAL INTRAVENOUS POWDER" for the University Hospital of Gran Canaria Dr Negrin

Spain, June 29 -- Spain based AMGEN, S.A has secured contract from Direccion Gerencia Hospital Universitario de Gran Canaria Doctor Negrin for Various medicinal products Supply of the active ingredient called "BLINATUMOMAB 38.5 MCG VIAL INTRAVENOUS POWDER" for the University Hospital of Gran Canaria Dr Negrin . The value of the contract is worth 11538500 EUR .

Published by HT Digital Content Services with permission from Pivotal Sources....